Jyong Biotech Ltd. (MENS)

Jyong Biotech Cash Flow Statement

Financials in millions USD. Fiscal year is January - December.

Year Ending	Dec 31, 2023	Dec 31, 2022	Dec 31, 2021
Net Income	-4.4	-6.63	-4.2
Depreciation & Amortization	0.13	0.12	0.12
Other Operating Activities	1.67	3.54	2.09
Operating Cash Flow	-2.6	-2.97	-1.98
Capital Expenditures	-	-0.25	-0.14
Change in Investments	0.1	1.64	-1.17
Investing Cash Flow	0.1	1.39	-1.31
Debt Issued / Paid	2.47	3.06	-1.38
Other Financing Activities	-0.45	0.28	-
Financing Cash Flow	2.03	3.33	-1.38
Net Cash Flow	-0.53	1.72	-4.61
Free Cash Flow	-2.6	-3.22	-2.12

Source: IPO financials are sourced from S-1 and S-1/A filings submitted to the Securities and Exchange Commission (SEC).